药品名称ADVIL LIQUI-GELS
申请号020402产品号001
活性成分IBUPROFEN市场状态非处方药
剂型或给药途径CAPSULE;ORAL规格EQ 200MG FREE ACID AND POTASSIUM SALT
治疗等效代码参比药物
批准日期1995/04/20申请机构PFIZER INC
化学类型New dosage form审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020402040APLetter2015/12/18下载
020402040APLabel2015/12/22下载
020402027APLetter2011/04/22下载
020402027APLabel2015/07/09下载
020402026APLetter2009/07/15下载
020402025APLetter2009/05/26下载
020402024APLetter2008/06/17下载
020402018APLetter2006/02/22下载
020402016APLetter2006/05/02下载
020402011APLetter2004/02/27下载
020402005APLetter2000/03/16下载
020402005APLabel2000/03/16下载
020402005APReview2003/07/08下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020402040AP2015/12/17Manufacturing Change or Addition
020402039AP2014/09/12Manufacturing Change or Addition
020402037AP2012/12/11Manufacturing Change or Addition
020402036AP2012/12/05Manufacturing Change or Addition
020402027AP2011/04/20Labeling Revision
020402026AP2009/07/09Manufacturing Change or Addition
020402025AP2009/05/19Labeling Revision
020402024AP2008/06/12Labeling Revision
020402018AP2006/02/08Labeling Revision
020402016AP2006/04/28Labeling Revision
020402011AP2004/02/26Labeling Revision
020402007AP2001/08/02Control Supplement
020402006AP2000/03/28Control Supplement
020402005AP2000/03/16New or Modified Indication
020402004AP1999/04/09Control Supplement
020402003AP1999/02/05Package Change
020402002AP1998/02/23Labeling Revision
020402001AP1997/10/06Manufacturing Change or Addition
020402000AP1995/04/20Approval